However, we found that, in GEJ adenocarcinoma, the loss of MTA3 was associated with several clinicopathologic indicators, including poor tumor differentiation, advanced disease stage, lymph node and distant metastasis, increased Snail expression, and decreased E-cadherin expression. The gene discussed is MTA3; the disease is gastroesophageal junction adenocarcinoma.